MedPath

Initial Assessment of an Internet-based Symptom Management Intervention in Early Stage Breast Cancer

Not Applicable
Completed
Conditions
Breast Cancer
Fatigue
Pain
Insomnia
Interventions
Behavioral: PROSPECT
Registration Number
NCT02495155
Lead Sponsor
University of Michigan
Brief Summary

In order to determine the acceptability of a breast cancer-specific cognitive behavioral therapy intervention, as well as to obtain preliminary data to assess efficacy in managing symptoms, the investigators will ask 45 breast cancer survivors with moderate insomnia, fatigue, and/or pain to use the investigators' internet-based intervention for 8 weeks and to complete patient-reported outcomes assessments before and after the 8 week intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
45
Inclusion Criteria
  • Female

  • Stage 0-III invasive carcinoma of the breast

  • Surgical resection and axillary assessment, radiation therapy, and/or chemotherapy, as indicated, completed at least 3 months prior to enrollment.

  • Concomitant trastuzumab and anti-endocrine therapies are permitted. If taking anti-endocrine therapy must have been taking for at least 3 months prior to enrollment.

  • Must report at least one of the following:

    1. Fatigue in the week prior to enrollment at least 4 on a 10 point scale (with 0 = not tired at all and 10 = extremely tired)
    2. Insomnia in the week prior to enrollment
    3. Pain in the week prior to enrollment at least 4 on a 10 point scale (with 0 = no pain and 10 = extremely severe pain)
  • Has access to and is able to operate a computer with internet access.

  • Able to read and understand English.

  • Willing and able to sign an informed consent document.

Read More
Exclusion Criteria
  • Diagnosis of sleep apnea or restless leg syndrome that is currently interfering with sleep
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
FatiguePROSPECTParticipants who have received treatment for early stage breast cancer and who experience fatigue, rated at least a 4 on a scale of 0-10 during the previous week, per patient report. Participants will complete baseline symptom questionnaires, then complete an internet-based cognitive behavioral therapy program (PROSPECT) for 8 weeks, then repeat questionnaires.
InsomniaPROSPECTParticipants who have received treatment for early stage breast cancer and who experience insomnia, assessed as difficulty sleeping over the last week, yes or no, per patient report. Participants will complete baseline symptom questionnaires, then complete an internet-based cognitive behavioral therapy program (PROSPECT) for 8 weeks, then repeat questionnaires.
Treatment-related PainPROSPECTParticipants who have received treatment for early stage breast cancer and who experience pain, rated at least a 4 on a scale of 0-10 during the previous week, per patient report. Participants will complete baseline symptom questionnaires, then complete an internet-based cognitive behavioral therapy program (PROSPECT) for 8 weeks, then repeat questionnaires.
Primary Outcome Measures
NameTimeMethod
Improvement in patient-reported symptom with use of PROSPECT for 8 weeks8 weeks

To obtain preliminary data about the efficacy of the intervention in this patient population. The investigators will assess change in the participant's primary reported symptom (pain, insomnia, or fatigue) with 8 weeks of the intervention.

Secondary Outcome Measures
NameTimeMethod
Acceptability of the PROSPECT intervention based on patient self-report8 weeks

To obtain preliminary data about the acceptability and usability of the intervention in this patient population.

Trial Locations

Locations (1)

University of Michigan Comprehensive Cancer Center

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath